Vitamin D-resistant rickets-Reference-Cited by-同舟云学术

Vitamin D-resistant rickets

Published:1964-02 Issue:2 Volume:36 Page:222-232
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Burnett Charles H.,Dent Charles E.,Harper Christine,Warland Barbara J.

Publisher

Elsevier BV

Subject

General Medicine

Reference19 articles.

1. Rickets and osteomalacia from renal tubular defects;Dent;J. Bone & Joint Surg.,1952

2. Hereditary forms of osteomalacia;Dent;J. Bone & Joint Surg.,1956

3. A genetic study of familial hypophosphatemia and vitamin D resistant rickets with a review of the literature;Winters;Medicine,1958

4. Familial hypophosphatemia with vitamin D resistant rickets. ii. Three additional kindreds of the sex-linked dominant type with a genetic analysis of four such families;Graham;Am. J. Human Genet.,1959

5. Familial hypophosphatemia and vitamin D resistant rickets;Williams,1960

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Burosumab treatment of X-linked hypophosphatemia patients: interim analysis of the SUNFLOWER longitudinal, observational cohort study;JBMR Plus;2024-06-10

2. Safety and Efficacy of Burosumab in Pediatric Patients With X-Linked Hypophosphatemia: A Phase 3/4 Open-Label Trial;Journal of the Endocrine Society;2022-02-11

3. What are the benefits of the anti-FGF23 antibody burosumab on the manifestations of X-linked hypophosphatemia in adults in comparison with conventional therapy? A review;Therapeutic Advances in Rare Disease;2022-01

4. Long-term effect of conventional phosphate and calcitriol treatment on metabolic recovery and catch-up growth in children with PHEX mutation;Journal of Pediatric Endocrinology and Metabolism;2021-09-16

5. Population Pharmacokinetics and Pharmacodynamics of Burosumab in Adult and Pediatric Patients With X‐linked Hypophosphatemia;The Journal of Clinical Pharmacology;2021-08-27